Olympiad Research’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-23,666
Closed -$217K 322
2021
Q2
$217K Buy
+23,666
New +$138K 0.08% 216

Other funds holding KIN

Olympiad Research's KIN Position: Q3 2021 in Review

Olympiad Research sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 23,666 shares — an estimated $217K sold.

Olympiad Research first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $217K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Olympiad Research reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Olympiad Research sold 23,666 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $217K.
  • Olympiad Research first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Olympiad Research's Kindred Biosciences, Inc. position peaked at $217K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Olympiad Research's 13F filing for Q3 2021, filed 9 Nov 2021.